Category:

Disaster & Management

Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet

Glenmark last month received Indian regulatory approval to make and sell anti-flu drug favipiravir, which is manufactured under the brand name Avigan by a unit of Japan’s Fujifilm Holdings Corp.

Glenmark had priced FabiFlu at 103 rupees per tablet earlier, making it one of the cheapest COVID-19 treatment available in the country.

“Glenmark’s price reduction aims to make FabiFlu further accessible for COVID-19 patients across the country,” the company said in a statement

read more

Early detection of Covid cases has resulted in low fatality rate: Vardhan

India’s total coronavirus cases have increased to 8,49,553. The country now has 2,92,258 active cases out of the total that were confirmed positive. Yesterday, the tally breached the 8-lakh mark. The total number of deaths that have been reported so far has increased to 22,674. India reported 28,637 new cases in the last 24 hours.

read more

Biocon secures approval to use drug on coronavirus patients

“The randomised control trial indicated that all the patients treated with Itolizumab responded positively and recovered,” said Kiran Mazumdar-Shaw, the firm’s executive chairperson.

The control group which did not receive Itolizumab unfortunately suffered deaths, she said, adding that the “first-in-class” drug will save lives and help reduce the mortality rate in India.

read more